Showing 1 - 10 of 293
Persistent link: https://www.econbiz.de/10007880086
Persistent link: https://www.econbiz.de/10008084755
Persistent link: https://www.econbiz.de/10007981297
In the United States, the Food and Drug Administration (FDA) provides public oversight of the safety and efficacy of drugs; medical devices; biologics like vaccines and blood products; cosmetics; radiation-emitting electronic products; veterinary products; and all foods, except meat and poultry...
Persistent link: https://www.econbiz.de/10005820082
In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating the safety and efficacy of biopharmaceutical drug products. Furthermore, the FDA is tasked with speeding new medical innovations to market. These two missions create an inherent tension within the...
Persistent link: https://www.econbiz.de/10005084693
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002, mandating FDA performance goals in reviewing and acting on drug applications within specified time periods. In turn, the FDA was permitted to levy user fees on drug sponsors...
Persistent link: https://www.econbiz.de/10005084928
Persistent link: https://www.econbiz.de/10005073501
Persistent link: https://www.econbiz.de/10005105546
The US Food and drug Administration (FDA) is estimated to regulate markets accounting for about 20% of consumer spending in the US. This paper proposes a general methodology to evaluate FDA policies, in general, and the central speed-safety tradeoff it faces, in particular. We apply this...
Persistent link: https://www.econbiz.de/10005580068
Persistent link: https://www.econbiz.de/10007984385